39 results
Page 2 of 2
424B5
g08zdw
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
bm6akk
15 Nov 21
Prospectus supplement for primary offering
5:24pm
8-K
tyu13a
30 Jun 21
Other Events
4:16pm
8-K
EX-99.1
r1wt7f3l
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
EX-1.1
hxe u6rzu
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
POS AM
EX-1.2
vnftf5le6eag3t c6e
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
424B5
jx7ekijqegeb
7 Mar 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
oawpwjo
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
424B5
jmjkra6wf35x
6 Mar 19
Prospectus supplement for primary offering
4:07pm
S-3ASR
EX-1.2
yxpd847tswbetm91
28 Dec 18
Automatic shelf registration
4:37pm
10-K
6rnbh vtydkce
19 Mar 18
Annual report
12:00am